Recently, Dassault Systèmes (3DS) held its much anticipated annual analysts’ meeting. Being a virtual meeting, we missed out on the fabulous hospitality that we are used to, but it still gave us access to the top management team. COVID-19 did not only affect our meeting, but it also had a significant impact on 3DS. We remember 12 months ago at the 2019 analyst days, the surprise announcement that 3DS had acquired Medidata, the leader in clinical trials software for life sciences. 3DS solutions now support 50% of the world’s COVID clinical trials, and life sciences has quickly risen to the top three industries served.
Read More